Guangzhou Baishi Medical Technology Co., Ltd. announced that it has raised CNY100 million in a round of funding from Strategy Capital, Coco Capital, and Koninklijke Philips N.V. on December 22, 2022. The transaction included participation from returning investor Guangzhou Cher Ami Investment Group Co., Ltd, and Beijing JHF Investment Management,. Xiaolin Wei of Guangzhou Cher Ami Investment Group Co., Ltd., and Bill Chen of Koninklijke Philips N.V. will join the board of directors of the company as part of the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.04 EUR | +0.08% | +26.82% | +18.76% |
03/05 | Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio | MT |
02/05 | PHILIPS NV : DZ Bank reiterates its Neutral rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.76% | 24.39B | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Guangzhou Baishi Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Strategy Capital, Coco Capital, Beijing JHF Investment Management, Guangzhou Cher Ami Investment Group Co., Ltd., Koninklijke Philips N.V.